proligestone has been researched along with medroxyprogesterone acetate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ordelman, GJ | 1 |
| Oldenkamp, EP; van Laar, PH; van Os, JL; Verschoor, JS | 1 |
| Mol, JA; Selman, PJ; van den Ingh, TS; van Garderen, E | 1 |
| Mol, JA; Selman, PJ; Wolfswinkel, J | 1 |
| Mol, JA; Rijnberk, A; Rutteman, GR; Selman, PJ; van den Ingh, TS; van Garderen, E | 1 |
| Arnold, S; Hubler, M; Meisl, D | 1 |
| Driancourt, MA; Huszenicza, G; Kulcsár, M; Proháczik, A; Trigg, T | 1 |
7 other study(ies) available for proligestone and medroxyprogesterone acetate
| Article | Year |
|---|---|
[The occurrence of mammary tumors in bitches following treatment with Delvosteron injection or Perlutex injection for the prevention of estrus, compared to 2 control groups].
Topics: Animals; Dog Diseases; Dogs; Female; Mammary Glands, Animal; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Progesterone; Progesterone Congeners | 1984 |
Oestrus control and the incidence of mammary nodules in bitches, a clinical study with two progestogens.
Topics: Animals; Contraception; Dog Diseases; Dogs; Female; Mammary Glands, Animal; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Progesterone; Progesterone Congeners | 1981 |
Comparison of the histological changes in the dog after treatment with the progestins medroxyprogesterone acetate and proligestone.
Topics: Adrenal Cortex; Animals; Antineoplastic Agents, Hormonal; Atrophy; Chemical and Drug Induced Liver Injury; Contraceptive Agents, Female; Delayed-Action Preparations; Dog Diseases; Dogs; Female; Fibroadenoma; Hysterectomy; Kidney Diseases; Liver Diseases; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Ovariectomy; Progesterone; Progesterone Congeners | 1995 |
Binding specificity of medroxyprogesterone acetate and proligestone for the progesterone and glucocorticoid receptor in the dog.
Topics: Animals; Dexamethasone; Dogs; Female; Hydrocortisone; Medroxyprogesterone Acetate; Progesterone; Protein Binding; Radioligand Assay; Receptors, Glucocorticoid; Receptors, Progesterone; Tritium | 1996 |
Effects of progestin administration on the hypothalamic-pituitary-adrenal axis and glucose homeostasis in dogs.
Topics: Adrenocorticotropic Hormone; Animals; Binding, Competitive; Depression, Chemical; Dogs; Female; Glucose; Homeostasis; Hydrocortisone; Hypothalamo-Hypophyseal System; Medroxyprogesterone Acetate; Pituitary-Adrenal System; Progesterone; Progesterone Congeners; Protein Binding; Receptors, Glucocorticoid; Receptors, Progesterone | 1997 |
[Treatment of fibroepithelial hyperplasia (FEH) of the mammary gland in the cat with the progesterone antagonist Aglépristone (Alizine)].
Topics: Animals; Cat Diseases; Cats; Chlormadinone Acetate; Estrenes; Female; Hyperplasia; Male; Mammary Glands, Animal; Medroxyprogesterone Acetate; Progesterone; Progesterone Congeners; Treatment Outcome | 2003 |
Comparison of four treatments to suppress ovarian activity in ferrets (Mustela putorius furo).
Topics: Animals; Chorionic Gonadotropin; Contraceptive Agents, Female; Drug Implants; Estrus; Female; Ferrets; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone Acetate; Ovulation; Pregnancy; Pregnancy Rate; Progesterone; Random Allocation; Triptorelin Pamoate | 2010 |